期刊文献+

抗心磷脂抗体与狼疮肾炎肾小球微血栓形成的临床研究 被引量:5

Correlation study of anticardiolipin antibody and glomerular microthrombi in lupus nephritis
原文传递
导出
摘要 目的探讨系统性红斑狼疮(SLE)患者抗心磷脂抗体(ACL)与狼疮。肾炎肾小球微血栓(GMT)形成的相关性,并探讨与狼疮肾炎GMT形成相关的临床因素。方法回顾性分析2005年1月至2010年10月中日友好医院收治的狼疮肾炎患者的年龄、性别、肾脏及肾外表现等因素对狼疮肾炎伴GMT形成的影响。酶联免疫吸附试验(ELISA)法检测患者血清抗心磷脂抗体(ACL)水平,采用,检验和Logistic回归模型进行分析。结果①126例狼疮肾炎患者纳入研究,其中38例伴发GMT形成,88例无GMT形成,通过对照研究,狼疮肾炎伴GMT形成组系统性红斑狼疮疾病活动指数(SLEDAI)、尿蛋白定量(24h)、血清肌酐、血清尿素氮的水平、抗双链DNA(dsDNA)抗体阳性、严重高血压、贫血和血小板减少、关节炎的发生率都较狼疮肾炎无GMT形成组高(P均〈0.01)。Logistic多因素回归分析显示SLEDAI评分[比值比(OR)=2.486,95%可信区间(CI)1.678-3.684,P=0.000]、贫血(OR=4.628,95%CI1.045-20.496,P=0.044)与狼疮肾炎伴发GMT形成相关。②肾活检病理结果显示,GMT在狼疮肾炎中的发生率为30.2%(38例),秩和分析发现伴GMT形成的狼疮肾炎患者肾脏病理损伤重(P=0.012),狼疮肾炎无GMT与狼疮肾炎伴GMT形成2组肾脏病理分型Ⅳ型狼疮肾炎的比例分别为38%与76%,HI型狼疮肾炎的比例分别为31%与8%。③狼疮。肾炎伴GMT形成组ACL的阳性率较狼疮肾炎无GMT形成组高,分别为61%(23例)和36%(15例),差异有统计学意义(P=O.018)。结论GMT形成在狼疮肾炎中并不罕见,SLEDAI、贫血、ACL阳性与GMT形成相关,狼疮肾炎伴发GMT患者肾脏病理损伤重。 Objective To explore the correlation of anticardiolipin antibody (ACL) and lupus nephritis (LN) glomerular microthrombi (GMT) in patients with systemic lupus erythematosus (SLE) and to analyze their clinical manifestations and renal pathological characteristics. Methods The clinical data of 126 LN patients treated at our hospital between January 2005 and October 2010 were retrospectively reviewed. The factors, including age, gender,the clinical manifestations in and outside of kidney were evaluated by multivariate Logistic regression analysis. Enzyme-linked immunosorbent assay (ELISA) was used to test the serum levels of ACL in all patients. Statistical analysis was conducted using X^2 test and Logistic regression. Results ①All 126 patients were investigated. Thirty-eight LN patients had GMT. When compared with the LN-non-GMT group, the SLE disease activity index (SLEDAI), urinary protein quantity (24 h), serum ereatinine, serum urea nitrogen, anti-dsDNA antibody (+), the incidence of severe hypertension, anemia, thromboeytopenia, arthritis were higher in the LN-GMT group (P〈0.01). Logistic regression analysis showed that SLEDAI (OR= 2.486, 95%CI 1.678-3.684, P=-0.000), anemia (OR=4.628, 95%Cl 1.045-20.496, P=-0.044) were correlated with GMT; ②The pathologic results of renal biopsy showed that GMT had an incidence of 30.2% (n=38) in LN. As compared with the LN-non-GMT group, Wileoxon test showed that the LN-GMT group suffered more severe greater renal pathological injuries (P=0.012). The pathological types of LN-non-GMT and LN-GMT groups were as follows: type Ⅳ (38% vs 76%) and type Ⅲ (31% vs 8%); ③ The positive rate of ACL was higher in the LN-GMT group than that in the LN-non-GMT group (n=23, 61% vs n=15, 36% ). The differences were statistically significant (P=0.018). Conclusion GMT is not rare in LN. SLEDAI, anemia and positive ACL are correlated with GMT, LN patients with concurrent GMT have more severe renal pathologicalchanges.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2012年第10期657-660,共4页 Chinese Journal of Rheumatology
关键词 狼疮 肾炎 抗体 抗心磷脂 肾小球微血栓 Lupus nephritis Antibody, anticardiolipin Glomerular microthrombi
  • 相关文献

参考文献14

  • 1Hill GS, Delahousse M. A new morphologic index for the evalua-tion of renal biopsies in LN. Kidney Int,2000, 58: 11-60.
  • 2Kant KS, Poliak VE, Weiss MA,et al. Glomemlar thrombosis insystemic lupus erythematosus: prevalence and significance.Medicine, 1981,60: 71-86.
  • 3Tektonidou MG, Sotsiou F,Nakonpoulou L, et al. Antiphos-pholipid syndrome nephropathy in patients with systemic lupuserythematosus and antiphosphohpid antibodies-prevalence,clinical associations,and long-term outcome. Arthritis Rheum,2004,50: 2569-2579.
  • 4Hughson MD, Nadasdy T, McCarty GA,et al. Renal thromboticmicroangiopathy in patients with systemic lupus erythematosusand antiphospaolipid syndrome. Am J Kidney Dis,1992, 10: 150.
  • 5Klemperer P, Pollack AD BG. Pathology of disseminated lupuserythematosus. Ach Pathol, 1941,32: 569.
  • 6Cohen D, Koopmans M, Kremer-Hovinga IC, et al. Potential forGlomerular C4d as an indicator of thrombotic microangiopathy inlupus nephritis. Arthritis Rheum, 2008, 58: 2460-2469.
  • 7Kant KS, Poliak VE,Weiss MA, et al. Glomerular thrombosis insystemic lupus erythematosus: prevalence and significance.Medicine (Baltimore),1981,60: 71-86.
  • 8刘俊铎,沈克勤,刘志红,陈惠萍,黎磊石.弥漫增殖型狼疮性肾炎按血管病变为基础的病理分型探讨[J].肾脏病与透析肾移植杂志,1998,7(3):235-242. 被引量:18
  • 9Appel GB, Priani CL. Renal vascular complications of systemiclupus erythematosus. J Am Soc Nephrol, 1994,4: 1499.
  • 10Descombes E,Droz D,Drouet L, et al. Renal vascular lesions inlupus nephritis. Medicine, 1997,76: 355.

二级参考文献3

共引文献17

同被引文献43

  • 1陈兰,李国贤,凌毅生,郭汉城.血清抗心磷脂抗体与系统性红斑狼疮肾小球微血栓形成之间的关系[J].血栓与止血学,2006,12(1):9-12. 被引量:1
  • 2王海燕主编.肾脏病学[M].第2版.北京:人民卫生出版社.2001,703-705
  • 3No6mie, Jourde-Chiche, Laurent. Association between anti-Clq antibodies and glomerular tuft necrosis in lupus nephritis[J].Clinical nepbrology, 2012, 77(03):588.
  • 4Maria, Dall'Era, David. Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide[J]. Arthritis care & research, 2011,63(03):358.
  • 5李焱,崔鹤仙,索晓慧.系统性红斑狼疮患者Th1/Th2细胞因子的研究[J].中国现代医学杂志,2007,17(22):2748-2750. 被引量:7
  • 6E1-Shafey EM, Abdou SH, Shareef MM. Is mycophenolate mofetil superior to pulse intravenous cyclophosphamide for induction therapy ofproliferative lupus nephritis in Egyptian patients[J]. Clin Exp Nephrol,2010,14:214 -221.
  • 7Hsieh YP,Wen YK,Chen ML. The value of early renal biop- sy in systemic lupus erythematosus patients presenting with renal involvement[J]. Clin Nephrol, 2 012,7 7 ( 1 ): 18-2 4.
  • 8Piecirillo CA, Lottefio JJ, Thornton AM, et al. CD4 ( + ) CD25 ( + ) regulatory T ceils can mediate suppressor function in absence of transforming growth factor betal-1 production and responsiveness [J]. J Exp Med ,2002,196:237-246.
  • 9Sandberg JK, Fast NM, Palacios EH, et al. Selective loss of innate CD4( + )V alpha 24 natural killer T cells in human immunodefi- ciency virus infection [ J ]. J Virol, 2002,76 ( 15 ) : 7528-7534.
  • 10Sanz I, Lee FE. B cells as therapeutic targets in SLE [ J ]. Nat Rev Rheumatol,2010,6(6) : 326-337.

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部